GlassScriptPhysician profile
Byron T Slaton
NPI 1770692527
$1,143.65
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $58.64 · 2021: $137 · 2022: $79.21 · 2023: $65.70 · 2024: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383 · Education: $17.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.53 |
| Education | $17.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $333.58 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.62 | 2023-2024 | Jardiance |
| Bard Peripheral Vascular, INC. | $152.03 | 2019-2023 | Pristine |
| Akebia Therapeutics INC | $111.38 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $81.70 | 2021-2022 | |
| Becton, Dickinson and Company | $78.69 | 2024 | |
| Alexion Pharmaceuticals, INC. | $78.29 | 2019-2024 | Ultomiris |
| Opko Pharmaceuticals, LLC | $38.22 | 2021-2023 | Rayaldee |
| Ani Pharmaceuticals, INC. | $22.32 | 2024 | Purified Cortrophin Gel |
| Aurinia Pharma U.S., INC. | $18.45 | 2024 | Lupkynis |
| Glaxosmithkline, LLC. | $17.32 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.04 | 2019 | |
| Fresenius USA Marketing, INC. | $14.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Byron Slaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.